<DOC>
	<DOCNO>NCT01625650</DOCNO>
	<brief_summary>The CORRONA CERTAIN Sub-study Consortium Rheumatology Researchers North America , Inc. Sub-study CORRONA Data Collection Program . The CERTAIN Sub-study design systematically collect document use pattern , effectiveness , comparative effectiveness safety biologic agent use management Rheumatoid Arthritis ( RA ) .</brief_summary>
	<brief_title>Effectiveness Registry Study Therapies Arthritis Inflammatory Conditions : The Corrona CERTAIN Sub-study</brief_title>
	<detailed_description>Biologic therapy ( include biologic medication like Enbrel , Humira , Remicade , Cimzia , Simponi , Actemra , Rituxan Orencia ) change treatment RA , difference safety and/or effectiveness biologic therapy know . We study order try see one treatment good others . The use databases like CORRONA Organization database give u information help u understand drug use , reason start stop drug , prescribe , monitor change patient ' ability perform daily activity gather information family social history .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>The CORRONA CERTAIN Substudy particularly focus understanding effectiveness safety biologic medication . Male female patient , 1. least 18 year age ; 2. document diagnosis RA treat rheumatologist ; 3. least moderate disease activity ; 4. initiate biologic agent use treatment past eligible participate . Moderate disease activity define CDAI score great 10 . Disease RA meet inclusion criterion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Rheumatoid Arthritis</keyword>
	<keyword>Registry</keyword>
	<keyword>RA</keyword>
	<keyword>Biologic</keyword>
	<keyword>Medications</keyword>
	<keyword>Rheumatology</keyword>
</DOC>